2 completed, 2 not yet recruiting, 2 recruiting, 1 terminated. 2 Phase 4, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Recruiting 1, Terminated 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
| Phase 3 | 1 | Completed 1 |
Follow Rimegepant 75 MG: new trials by email Literature Review of Rimegepant 75 MG trials Research Report on Rimegepant 75 MG
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rimegepant For Endometriosis Pain Rimegepant 75 MG, Placebo - Endometriosis, Endometriosis-related Pain | Phase 2 | Not yet recruiting | Mayo Clinic | 132 | 2026-09-30 | 2026-08-31 |
| Biological Profiles of Neuropeptides, Neurotrophins and miRNA in Migraine Rimegepant 75 MG - Migraine | Not yet recruiting | Nordlandssykehuset HF | 60 | 2026-09-17 | 2026-09-21 | |
| Rimegepant as Preemptive Treatment for Predictable Trigger-Induced Migraine in Adult Patients in the US Rimegepant 75 MG - Migraine, Trigger Induced Migraine | Phase 4 | Recruiting | Medstar Health Research Institute | 60 | 2025-09-09 | 2025-12-24 |
| RimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment Rimegepant 75 mg - Migraine, Migraine With Aura | Recruiting | University of Florence | 100 | 2024-03-26 | 2026-06-11 | |
| A Prospective Real World Study of Rimegepant in the Treatment of Migraine Rimegepant 75 MG - Migraine | Completed | Ruijin-Hainan Hospital Shanghai Jiao Tong University School Of Medicine | 173 | 2023-01-11 | 2026-02-05 | |
| Efficacy and Safety Study of Rimegepant for the Acute Treatment of Migraine in Japanese Subjects (Japan Only) Rimegepant 25 MG, Rimegepant 75 MG, Placebo - Migraine | Phase 3 | Completed | Pfizer | 897 | 2022-08-09 | 2025-03-07 |
| Evaluation of the Efficacy of Diclofenac Potassium and Rimegepant for the Acute Treatment of Migraine Diclofenac Potassium 50Mg/Pkt Oral Pwdr, Rimegepant 75 MG - Migraine With Aura, Migraine Without Aura | Phase 4 | Terminated | Danish Headache Center | 300 | 2022-05-05 | 2025-09-29 |
Migraine Disorders (5) · Headache (2) · Migraine with Aura (2) · Migraine without Aura (2) · Diabetes Insipidus (1) · Endometriosis (1) · Headache Disorders, Secondary (1) · Pain (1)
Danish Headache Center (1) · Mayo Clinic (1) · Medstar Health Research Institute (1) · Nordlandssykehuset HF (1) · Pfizer (1) · Ruijin-Hainan Hospital Shanghai Jiao Tong University School Of Medicine (1) · University of Florence (1)
United States (2) · China (1) · Denmark (1) · Italy (1) · Japan (1) · Norway (1)
Jessica Ailani, MD (1) · Jun Liu (1) · Karl B. Alstadhaug, MD, PhD (1) · Messoud Ashina, Prof. (1) · Yohannes Woldeamanuel, MD (1)